ProCE Banner Activity

Challenging the Current Treatment Paradigm for Patients With Follicular Lymphoma: Recent and Emerging Evidence

Tool

Use this Interactive Decision Support Tool to compare your approach for treating patients with follicular lymphoma with the strategies recommended by 5 expert hematologists.

Released: March 31, 2023

Share

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

John M. Burke, MD: consultant: Adaptive Biotechnologies, AstraZeneca, BeiGene, Bristol-Myers Squibb, Epizyme, Kura, Kymera, Morphosys, Novartis, Nurix, Roche/Genentech, SeaGen, TG Therapeutics, Verastem, X4 Pharmaceuticals; speaker: BeiGene, SeaGen; researcher: Morphosys.

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Jeff Sharman, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, AstraZeneca, BeiGene, Bristol Myers Squibb, Genentech, Janssen, Lilly, Merck.

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Christopher R. Flowers, MD, MS: consultant/advisor/speaker: AstraZeneca, Bayer, BeiGene, BioAscend, Bristol Myers Squibb, Celgene, Curio Sciences, Denovo Biopharma, Epizyme/Incyte, Foresight Diagnostics, Genentech/Roche, Genmab, MEI Pharmaceuticals, MorphoSys AG, N-Power, Pharmacyclics/Janssen, SeaGen; stock options: Foresight Diagnostics, N-Power; researcher (paid to institution): 4D, AbbVie, Acerta, Adaptimmune, Allogene, Amgen, Bayer, Celgene, Cellectis, EMD, Gilead, Genentech/Roche, Guardant, Iovance, Janssen, Kite, MorphoSys, Nektar, Novartis, Pfizer, Pharmacyclics, Sanofi, Takeda, TG Therapeutics, Xencor, Ziopharm.

Jean Louise Koff, MD, MSc

Assistant Professor
Department of Hematology/Oncology
Winship Cancer Institute
Emory University
Atlanta, Georgia

Jean L. Koff, MD, MSc: consultant: BeiGene, Janssen/Pharmacyclics, Gamida Cell, MorphoSys, TG Therapeutics; researcher: Atara, Celgene, Janssen/Pharmacyclics, Oncternal, Viracta.

Pallawi Torka, MD

Assistant Professor of Oncology
Lymphoma Division
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Pallawi Torka, MD: consultant/advisor/speaker: ADC Therapeutics, Genentech, Lilly, Seagen, TG Therapeutics.